Therefore, an in‐depth study of the mechanism of action of SWI/SNF complex in tumours can provide sufficient theoretical basis for drug development, clinical adjuvant diagnosis and treatment of tumours caused by its mutations. The gene discussed is SMARCA1; the disease is neoplasm.